Clinical Trial Update: Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of liposomal doxorubicin in liver cancer and biliary tract cancers (including extrahepatic bile duct cancer and gallbladder cancer) is reported; c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: Brown University | Conditions: Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 2 | Status: UNKNOWN